Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Praxis Precision Medicines Inc PRAX

Healthcare Biotechnology
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PRAX)

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome

GlobeNewswire 7 days ago

Praxis Precision Medicines to Present at Upcoming December Investor Conferences

GlobeNewswire December 3, 2024

Praxis Precision Medicines to Showcase Updates from Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting

GlobeNewswire November 26, 2024

Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences

GlobeNewswire November 6, 2024

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire November 6, 2024

Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024

GlobeNewswire November 1, 2024

Praxis Precision Medicines presents on ulixacaltamide Essential3 program at the Movement Disorders Society 2024 International Congress

GlobeNewswire September 26, 2024

Praxis Precision Medicines to Participate in Upcoming Investor Conferences

GlobeNewswire September 5, 2024

Praxis Precision Medicines to highlight their Epilepsy Portfolio at the International League Against Epilepsy 15th European Epilepsy Congress with six presentations

GlobeNewswire September 4, 2024
View More News ››

Opinion & Analysis (NDAQ:PRAX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PRAX)

Praxis Precision Medicines to Showcase Updates from Largest

BREAKING NEWS: $PRAX Praxis Precision Medicines to Showcase Updates from Largest Epilepsy Pipeline of Precision Epilepsy Programs at the...
whytestocks - November 26, 2024

Praxis Precision Medicines Provides Corporate Update and Rep

NEWS: $PRAX Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial ResultsUp to four programs in...
whytestocks - August 13, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX): A Promising

http://beyondspx.com/2024/08/01/praxis-precision-medicines-inc-nasdaqprax-a-promising-biopharmaceutical-company-translating-genetic...
MikeTester - August 1, 2024
View more Bullboard ››

Alphamin Resources Corp.

Alphamin Resources Corp.

Alphamin Resources Corp. is a Mauritius-based company, which is engaged in the production and sale of tin concentrate from ...
View More »